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Abstract 
 
In 2010, the Obama administration passed the Patient Protection and Affordable Care Act (ACA) 
commonly known as Obamacare. However, it is in 2014 that several key parts of the ACA went 
into effect. Among those key parts is the Medicaid expansion program. States that chose to adopt 
the policy, expanded Medicaid access to everyone under 138 percent of the federal poverty line. 
This extension had the largest impact on childless adults who previously were not covered by the 
program. Moreover, ACA made it mandatory for all health plans (private and public) to include 
the ten essential health benefits in their most basic packages. One of the 10 essential benefits is 
preventive care that includes cancers’ screenings. Consequently, screenings became more 
affordable and accessible for millions of individuals across the country. Using the Behavioral 
Risk Factor Surveillance System (BRFSS), I estimated the impact of the ACA policy changes to 
make breast and cervical cancer screenings more available. My results were not significant 
enough to draw any conclusions. It is likely that the limitations I encounter with my data sample 
(breast and cervical cancer screenings questions were only available for even years in the BRFSS 
Database), reduced my ability to analyze any significant trends. However, I found out that 
having an insurance and a health care provider was highly correlated with the respondents 
following cancer screenings guidelines (every three years for pap smear and every two years for 
mammograms). 
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Introduction 
On March 23rd, 2010, the Obama administration passed the Patient Protection and 
Affordable Care Act (ACA) commonly known as Obamacare. Obamacare was a comprehensive 
health care reform with three principal goals. One was to provide a more affordable health care 
coverage via subsidies (“premium tax credits”) that lowered healthcare costs for households with 
incomes between 100% and 400% of the federal poverty level. The second one was to support 
innovative medical care delivery methods with the aim to decrease health care cost in the long 
term. Lastly, the ACA aimed at expanding the already existing Medicaid program to cover all 
adults under the age of 65 with income below 138% of the federal poverty level. Prior to ACA, 
federal health agencies had strict categorical eligibility requirements which often excluded 
childless and non-pregnant women regardless of their income (Adams & Johnston, 2016). 
Through the enactment of the Medicaid expansion (ACA; Pub L No. 111–148), millions of low-
income females became eligible for health insurance in 2014. Moreover, ACA made it 
mandatory for private insurance to include family planning and preventive care services without 
copayments for women at 100% to 400% of the federal poverty level who are non-eligible for 
Medicaid. 
The ACA also made it mandatory for insurance companies to cover ten essentials health 
benefits among which was preventive care. The main objective for implementing these ten 
essential health benefits was to positively impact the health of the low and middle-income 
Americans whose health lag behind their peers in developed countries such as France, Canada, 
and Germany (Komlos & Lauderdale, 2007). Preventive care occupies a central place in public 
health and health economics as it is a valuable tool to address control health care spending in the 
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long term. Preventive care includes services such as cancer screenings, counseling and routine 
vaccines. 
According to the American Cancer Society, 13,170 new cases of invasive cervical 
cancers and 252,710 new cases of invasive breast cancer will be diagnosed in 2019. Although 
there are already several federal and state programs (pre-ACA expansion) supporting the 
provision of free or low‐cost cancer screenings to low‐income women, screening rates are still 
not optimal. This may be due to uninsured women being unaware of the benefits offered by such 
programs. Research has shown that higher cancer screening rates correlate with a decrease in 
rates in late-stage diagnosis of breast and cervical cancers. Unfortunately, death’s rates from 
these diseases are higher among underinsured and uninsured women. Women with either no 
health insurance or no regular health care source underuse mammograms and Pap tests (White et 
al., 2017). This may lead to the diagnosis of breast and cervical cancers at later stages explaining 
the high mortality rate among low income and minority women (Hiat et al., 2001). 
The U.S. Preventive Services Task Force - an independent panel of experts in primary 
care and prevention - recommends biennial screening mammography for women aged 50 to 74 
years and triannual Pap screening for women 21-65 years old, which can be extended to five 
years if the Pap smear is taken along the Human papilloma virus (HPV) vaccine. 
For this study, I explored the change in cancer and cervical screening rates among 
BRFSS respondents between the year of 2012 and 2016. I chose these two years as 2012 and 
2016 mark respectively two years before and after the enactment of the Medicaid expansion in 
2014. 
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In addition, the Obama government efforts were put to halt in 2012 with the ruling of 
National Federation of Independent Business v. Sebelius case by the United States Supreme 
Court. The ruling made the Medicaid expansion optional for states. Hence, they are separate 
groups of states, one that comprised states that expanded their Medicaid program (expansion 
states) and another that comprised those that did not (Non-Expansion States). 
These conditions created a natural experiment to study the effect of ACA Medicaid 
expansion across the country. In this study, I analyzed the impact of expanded insurance 
coverage through the Affordable Care Act on the rates of the two above mentioned cancer 
preventive services, Pap smear and mammogram among childless women. 
For this study, I hypothesized that the post ACA year (2016) will show higher screening 
rates in expansion states compared to states that did not expanded Medicaid.  
 
Literature Review 
Numerous studies have demonstrated that ACA Medicaid expansion had positive impacts 
on health coverage disparities and access to health care (Buchmueller, et al., 2017, p. 1416-
1421). However, there is still a lack of extensive research on the effect of the ACA Medicaid 
expansion on cancer preventive services. The few published ones present mixed results, some 
argue that the expansion has led to a shift towards an early-stage diagnosis of cancers such as 
cervical and breast cancers (Hang et al., 2016; Robins et al., 2015) while others did not find 
significant changes (Mehta et al., 2015). 
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 According to the National Cancer Institute, new cancer cases per year is expected to rise 
to 23.6 million by 2030. Hence, it is more than crucial to thoroughly study the effects of policies 
such as the Medicaid expansion. In addition, the United States as a country has been lagging in 
terms of health and health care disparities. It is not only essential to explore how instrumental 
extending public health insurance to a larger population, but also necessary to study if this action 
has an impact in health gap among different groups of people across the nation. 
Black and Hispanic women are more at risk of late-stage breast and cervical cancer 
diagnosis, which might be related to lack of access to prevention services due to numerous 
causes such as access (lack of knowledge about cancer and cancer screenings, fear of cancer, 
lack of primary doctor), lack of health insurance or fees of screening services (Breslow et al., 
2008).  
 
Materials and Methods 
Data 
Data from this study were obtained from the Behavioral Risk Factor Surveillance System 
(BRFSS). BRFSS data is a critically important and easy to access data-source for analysis 
because of the large comprehensive set of questions regarding health status and insurance 
coverage. It is a system of telephone surveys of more than 400,000 adults (≥18 years of age) U.S. 
residents. Samples are chosen to be state representative; a common set of questions are used 
across states, with flexibility for states to supplement their survey. BRFSS data, including survey 
weights, are publicly available through the Centers for Disease Control and Prevention 
commonly known as CDC. 
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Analytic Sample 
The study sample is composed of BRFSS 2012 and 2016 datasets merged together. The 
2012 dataset served as the pre-aca sample while the 2016 one was used as the post-ACA sample. 
At start, I first intended to use two years (2012, 2013) for the pre-expansion period and 2 years 
(2015-2016) as the post-expansion period. However, breast and cervical screening related 
questions were optional for the years of 2013 and 2015, meaning less than ten states per year had 
data related to mammograms or pap smear for those years. 2014 was not included as I considered 
it as the wash out period to study the impact of ACA. 
Moreover, the sample was restricted to childless non-pregnant women of 18-64 years old 
for pap smear screening rates analysis. While for breast cancer screening rate studies, the sample 
was limited to childless non-pregnant women 50-74 years of age. The age restrictions were done 
in accordance with the U.S. Preventive Services Task Force recommendations, while the focus 
on non-pregnant women was set because pregnant women were already cover prior through 
ACA. 
States like New York, California or Maine with early or late ACA Medicaid expansions 
or pre-ACA Medicaid waiver covering childless adults up to 100% of the Federal Poverty Level 
were excluded. Expansion states referred to states that implemented the ACA by January 2014 
while Non-Expansion states are those that did not implemented the ACA between January 2014 
and January 2016, see Table (1). 
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Table 1: States Classification 
Expansions States Non-Expansion States Excluded States 
Arkansas Alabama  Alaska 
Arizona Florida California 
Colorado Georgia Connecticut 
Delaware Idaho Kentucky 
Illinois Kansas District of Columbia 
Maryland Mississippi Hawaii 
Massachusetts Missouri Indiana 
Minnesota Nebraska Louisiana 
Nevada North Carolina Maine  
New Mexico Oklahoma Michigan 
North Dakota South Carolina Montana 
Ohio South Dakota New Hampshire 
Oregon Texas Iowa  
Rhode Island Utah New Jersey 
West Virginia Virginia New York 
Washington Wyoming Pennsylvania 
  Tennessee 
  Vermont 
  Wisconsin 
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Design and Variables 
This study used a quasi-experiment difference-in-difference (DID) approach. This 
analytic design tests a comparison of the change in trends of outcomes before and after Medicaid 
expansion across expansion states vs non-expansion states. The difference-in-differences method 
is widely used for assessing the effect of a policy change such as the Medicaid expansion. It 
involves subtracting the difference between the pre and post period for a control group from the 
same difference for a treatment group. With such method we can account for any co-founders 
that may affect the cancer screening rates before and after the Medicaid expansion.   
 
 
Analysis were conducted using STATA/IC 15.1. The dependents variables are indicators 
of access to preventive care services. For breast cancer screening rates, I established two 
indicators: one for whether or not a woman had a mammogram in her lifetime, and the other one 
for whether or not she had it in the past two years. For cervical cancer screening rates, two 
similar indicators were used as dependent variables one for whether or not a woman had a pap 
smear in her lifetime, and the other one is whether or not she had it in the past three years. 
Those indicators represent responses to the four following BRFSS survey questions: 
1) A mammogram is an x-ray of each breast to look for breast cancer. Have you ever had a 
mammogram? 
2 ) How long has it been since you had your last mammogram? 
3) A Pap test is a test for cancer of the cervix. Have you ever had a Pap test? 
4) How long has it been since you had your last Pap test? 
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To control for the effects of ACA, I included several socio-demographic factors that are 
usually associated with cancer screening use, including race/ethnicity (white, black non-
Hispanic, Hispanic, other non-Hispanic), first language (English, or other) marital status 
(married/living with partner, unmarried/not living with partner), existence of a health care 
provider (has at least one doctor, has no doctor) and health status (excellent/very good/good, 
fair/poor) as these have also been shown to be related to screening use (Aiken, et. al., 1994). 
It is important to note that although income is an important socio-demographic factor in 
health and healthcare, I decided to not include it in this study. As the BRFSS being a telephone 
survey, inaccuracy in income report might be an issue. Instead, I used education (did not 
graduate high school, graduate high school, attended college, graduated college) as a substitute 
for income as level of education is often highly correlated to income. 
 
Guided by the aforementioned, the following models were established: 
 
Mam= β1(expand) + β2(post) +  β3(post_expand)+ β4(marital status) +  β5(race) + β6 
(languagespoken) +  β7(education) + β8(age) +  β9(healthstatus) + β10(personalphysician)+ µ 
 
MamPast2= β1(expand) + β2(post) +  β3(post_expand)+ β4(marital status) +  β5(race) + β6 
(languagespoken) +  β7(education) + β8(age) +  β9(healthstatus) + β10(personalphysician)+ µ 
 
Pap= β1(expand) + β2(post) +  β3(post_expand)+ β4(marital status) +  β5(race) + β6 
(languagespoken) +  β7(education) + β8(age) +  β9(healthstatus) + β10(personalphysician)+ µ 
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PapPast3= β1(expand) + β2(post) +  β3(post_expand)+ β4(marital status) +  β5(race) + β6 
(languagespoken) +  β7(education) + β8(age) +  β9(healthstatus) + β10(personalphysician)+ µ 
 
Where Mam, MamPast2, Pap and PapPast3 are binary measures for respectively 
mammogram screening in lifespan, mammogram screening in the past two years, pap screening 
in lifespan, pap smear screening in the past three years. Race is a set of indicators for each 
minority or race group (Black Non-Hispanic, Other Non-Hispanic, Hispanic). Post_expand is the 
interaction term for postACA year and state effects. The coefficient β1 represents the main effect 
of state on outcomes while β2 represents the main effect of the ACA Medicaid expansion policy. 
The coefficient β3 capture the interaction effect between state effects and Medicaid expansion 
policy. When state fixed effects and year fixed effects are also included in the model, the 
coefficient of this variable measures the effect of the presence of an expansion on the likelihood 
of each outcome for childless women, holding other factors constant. 
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Table 2: Variables Description 
Variable Description 
mam 
Indicator for having a mammogram at least once in a lifetime 
mampast2 
Indicator for having a mammogram in the past two years 
Pap 
Indicator for having a pap test at least once in a lifetime 
Pappast3 
Indicator for having a pap test in the past three years. 
insurance 
Indicator for having health care coverage  
single 
Non-Married 
goodhealth 
Indicator for having Excellent/ Very good/ Good/ Fair Health 
doctor 
Indicator for having at least one primary care provider 
somehs 
Attended High School 
hsgrad 
Graduate from College 
somecol 
Attended College 
collegegrad 
College Graduate 
blacknonhis 
Black Non-Hispanic 
othernonhis 
Other Non-Hispanic 
his 
Hispanic white 
white 
Non-Hispanic white 
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Results 
 
Descriptive Statistics 
Table 2 shows the independent and defendant variables descriptions. 
Table 3 shows the weighted descriptive statistics of the sample which was limited to 
mammogram age-specific respondents (50-74 years old). In average, 96% percent of respondents 
had a mammogram at least once in their lifetime, while 81 percent respondents had their 
mammogram in the past two years. Among females in the expansion state, 83% of women are 
currently in good terms with screening guideline (had their mammogram in the past two years) 
compared to 81% in the non-expansion states. Overall, the population demographic in both the 
expansion and the non-expansion states are quite similar. 
Table 4 shows the descriptive statistics in year category (2012 vs 2016). While insurance 
rate among the respondent increased from 92% in 2012 to 96% in 2016, the percentage of 
women who got their mammogram in the past two years is lower by one percent in 2016 
compared to 2012. 
Table 5 and Table 6 show the weighted descriptive statistics for the pap smear sample 
(18-64 years old). 78 % of Women in expansion states had their mammogram in the past 3 years 
compared to 75% in non-expansion states. Table 5 shows a decrease in 2016 of the percentage of 
respondents who ever had a pap test and a pap test in the past three years, respectively 95% to 
93% and 78% to 75%. 
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Analysis Results 
In table 7, I show results from the difference-in-difference regression for the breast 
cancer screening rates indicators. The two dependent variables are mam (indicator for “having 
eve received a mammogram” and mampast2, the indicator for “having received a mammogram 
in the past two years”. Both variables are binary. Our primary interest is in the coefficients of the 
ACA Medicaid effect (PostACA) and the coefficients on the interaction of ACA Medicaid 
effects and state effects. Column one shows finding for “mam” indicator while column 2 shows 
finding for “mampast2” indicator. There does not appear to be significant difference between 
mammograms screening rates before and after the ACA expansion, other things controlled. 
However, the interaction term between states and ACA expansion for mammogram screening in 
the past two years is negative and statistically significant at p<0.01. Having an insurance and a 
doctor is strongly correlated with having received mammogram in the past two years. 
In table 8, I examined the main effects and interaction of state and ACA expansion on pap smear 
screening rates. The difference-in-difference model for this regression indicates that after the 
ACA expansion, the rates of pap smear rates were lowered by 4% (p<0.01). Education appears to 
have a positive correlation with having received the mammogram in the past three years. College 
grads, College drop-outs and High school graduates are respectively 10, 5 and 4 % more likely to 
be following the screening guidelines compare to high school dropouts (p<0.01). Having an 
insurance and a doctor is strongly correlated with having received pap smear in the past three 
years. Moreover, the younger the respondent, the higher the chance they had a mammogram in 
the past three years.  
 
 13 
Table 3: Descriptive Statistics for Age-Specific Breast Cancer Screening  
(Expansion States vs Non Expansion states)  
 
Variable Non-ExpansionState  ExpansionState  
Mean Mean 
mam 0.96 0.96 
mampast2 0.81 0.83    
insurance 0.93 0.95 
single 0.44 0.45 
goodhealth 0.92 0.94 
doctor 0.92 0.93    
somehs 0.09 0.06 
hsgrad 0.31 0.27 
somecol 0.30 0.30 
collegegrad 0.31 0.37    
blacknonhis 0.11 0.06 
othernonhis 0.04 0.04 
his 0.08 0.05 
white 0.77 0.85    
age50_54 0.14 0.14 
age55_59 0.20 0.20 
age60_64 0.23 0.24 
age65_69 0.23 0.23 
age70_74 0.20 0.19 
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Table 4: Descriptive statistics for Age-Specific Breast Cancer Screening  
Sample  (PreAcA vs PostAca) 
 
Variable PreAca(2012) PostAca(2016)  
Mean Mean 
mam 0.96 0.96 
mampast2 0.82 0.81    
insurance 0.92 0.95 
single 0.45 0.44 
goodhealth 0.93 0.93 
doctor 0.92 0.92    
somehs 0.08 0.07 
hsgrad 0.30 0.28 
somecol 0.29 0.30 
collegegrad 0.32 0.35    
blacknonhis 0.09 0.09 
othernonhis 0.04 0.04 
his 0.06 0.06 
white 0.81 0.81    
age50_54 0.16 0.13 
age55_59 0.21 0.19 
age60_64 0.23 0.23 
age65_69 0.22 0.25 
age70_74 0.18 0.20 
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Table 5: Descriptive Statistics for Age-Specific Cervical Cancer Screening Sample 
(Expansion States vs Non-Expansion states) 
Variable Non-Expansion 
State 
Expansion State 
 
Mean Mean 
pap 0.937 0.945 
Pappast3 0.755 0.781    
insurance 0.862 0.908 
goodhealth 0.933 0.943 
doctor 0.848 0.871 
single 0.450 0.461    
somehs 0.074 0.052 
hsgrad 0.273 0.245 
somecol 0.308 0.299 
collegegrad 0.345 0.404    
white 0.719 0.806 
blacknonhis 0.131 0.071 
othernonhis 0.052 0.058 
his 0.098 0.066    
age25_29 0.049 0.051 
age30_34 0.032 0.036 
age35_39 0.029 0.029 
age40_44 0.045 0.044 
age45_49 0.095 0.090 
age55_59 0.261 0.262 
age60_64 0.298 0.303 
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Table 6: Descriptive statistics for Age-Specific Cervical Cancer Screening Sample 
(PreAcA vs PostAca) 
Variable Pre ACA(2012) Post ACA(2016)  
Mean Mean 
pap 0.952 0.928 
Pappast3 0.785 0.747    
insurance 0.859 0.912 
goodhealth 0.936 0.940 
doctor 0.865 0.852 
single 0.459 0.452    
somehs 0.067 0.060 
hsgrad 0.264 0.255 
somecol 0.302 0.305 
collegegrad 0.368 0.380    
white 0.767 0.754 
blacknonhis 0.101 0.104 
othernonhis 0.055 0.055 
his 0.078 0.088    
age25_29 0.045 0.055 
age30_34 0.031 0.038 
age35_39 0.027 0.031 
age40_44 0.048 0.041 
age45_49 0.098 0.087 
age55_59 0.263 0.259 
age60_64 0.289 0.313 
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Table 7: Regression Results for Breast Cancer Screening 
 mam mampast2 
postaca -0.004 -0.003 
 (1.14) (0.57) 
post_expand 0.004 -0.019 
 (0.96) (2.35)* 
expansionstate -0.002 0.008 
 (0.87) (1.62) 
insurance 0.070 0.192 
 (9.71)** (16.10)** 
single -0.012 -0.044 
 (5.31)** (9.85)** 
goodhealth 0.002 0.090 
 (0.40) (8.53)** 
doctor 0.101 0.213 
 (14.69)** (19.03)** 
hsgrad 0.012 0.034 
 (2.07)* (3.80)** 
somecol 0.027 0.027 
 (5.08)** (2.96)** 
collegegrad 0.035 0.065 
 (6.58)** (7.36)** 
blacknonhis 0.016 0.095 
 (4.18)** (14.08)** 
othernonhis -0.011 -0.023 
 (1.67) (1.78) 
his 0.017 0.077 
 (3.31)** (8.57)** 
age55_59 0.014 -0.008 
 (3.75)** (1.14) 
age60_64 0.022 0.001 
 (5.69)** (0.21) 
age65_69 0.018 0.012 
 (5.36)** (1.88) 
age70_74 0.021 0.001 
 (6.42)** (0.08) 
_cons 0.770 0.325 
 (61.56)** (16.41)** 
R2 0.05 0.07 
N 148,473 141,631 
[All Results Rounded to the Nearest Ten Thousandth of a Point] * p<0.05; ** p<0.01 
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Table 8: Regression Results for Cervical Cancer Screening 
      Pap Pappast3 
postaca -0.032 -0.039 
 (5.83)** (6.25)** 
post_expand -0.002 0.006 
 (0.29) (0.73) 
expansionstate -0.002 -0.003 
 (0.53) (0.55) 
hsgrad 0.018 0.041 
 (1.91) (3.63)** 
somecol 0.052 0.050 
 (5.70)** (4.44)** 
collegegrad 0.077 0.101 
 (8.65)** (9.28)** 
blacknonhis 0.002 0.098 
 (0.23) (15.20)** 
othernonhis -0.110 0.022 
 (11.34)** (2.42)* 
his -0.044 0.108 
 (5.89)** (13.81)** 
insurance 0.019 0.144 
 (2.78)** (17.04)** 
goodhealth -0.006 0.117 
 (0.89) (9.82)** 
doctor 0.036 0.116 
 (5.41)** (16.22)** 
single -0.042 -0.031 
 (11.95)** (6.92)** 
age18_24 -0.409 0.270 
 (42.27)** (35.89)** 
age25_29 -0.082 0.234 
 (9.76)** (29.33)** 
age30_34 -0.042 0.202 
 (5.27)** (20.80)** 
age35_39 -0.017 0.173 
 (1.92) (16.29)** 
age40_44 0.003 0.130 
 (0.54) (11.39)** 
age45_49 0.008 0.100 
 (2.21)* (11.28)** 
age50_54 0.000 0.069 
 (0.06) (9.20)** 
age55_59 0.001 0.036 
 (0.21) (5.18)** 
_cons 0.929 0.318 
 (77.47)** (17.88)** 
R2 0.30 0.10 
N 121,818                                                113,357 
[All Results Rounded to the Nearest Ten Thousandth of a Point] * p<0.05; ** p<0.01 
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Discussion 
My results did not match my expectations. I expected to obtain significant coefficients for 
postACA and expansion state variables, as this would indicate the positive impact of Medicaid 
expansion shown by previous papers. Besides, not being statistically significant, most 
coefficients were negative. I suspect that this may be due to several reasons. First, each state has 
its own specific Medicaid program implementation conditions and requirements. While using the 
BRFFS, there is no specific way to account state specific effect among expansion or non-
expansion states. Moreover, the results showed having an insurance is a strong indicator to have 
either mammograms or pap smear in accordance with the cancer screening recommendations. 
With most insurance nowadays including mammogram at no cost or minimal copay, the impact 
of ACA Medicaid expansion may not be noticeable. It might also be too early to track the effect 
of a 2014 policy on prevention services such as cancer screenings. Moreover, 2016 had overall a 
lower proportion of respondents (N=39896) who had pap tests compared to 2012 (48828). This 
might expand the negative coefficient for the interaction post_expand indicator. In 2011, The 
Affordable care act created the Medicaid incentives for the prevention of chronic disease which 
awarded five years grants to ten states to provide incentives to Medicaid beneficiaries who 
participated in prevention programs, among those states are California, Connecticut, Minnesota 
included in our expansion state group.  The early implementation of such policies may have built 
up the number of respondents who got their screenings. They are several local county health 
departments and women’s clinics that provide mammogram and pap smear Free or Low-Cost 
Pap smears. The national breast and cervical cancer early detection program is a federally funded 
program that helps uninsured and impoverished women get regular mammograms and pap smear 
according to the cancer screening guideline. The program is available to eligible low-income 
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women ages 18-64 without insurance or whose insurance does not cover cervical and breast 
screening cost.  
Limitation 
This study had several limitations. One of the strongest one is the data set. Since cancer 
and cervical screenings questions were optional in 2013 and 2015, and we used 2014 as a 
washout year, we had only 2012 data for our pre-ACA period and 2016 for the post-ACA period. 
This left us with only two years to explore the impact of a complex policy such as the Medicaid 
expansion.  
 
Conclusion 
My results were not significant enough to draw any conclusions. They did not support my 
hypothesis which was that the post ACA year (2016) would show higher screening rates in 
expansion states compared to states that did not expanded Medicaid.   It is likely that the 
limitations I encounter with my data sample has an effect on my analysis. Future work should 
continue to monitor cancer preventive services rates in populations targeted by the Medicaid 
expansion. They add to the literature on the effect of the importance of insurance and the impact 
of education. 
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